Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 27  •  04:00PM ET
14.50
Dollar change
-0.09
Percentage change
-0.62
%
IndexRUT P/E- EPS (ttm)-0.39 Insider Own5.97% Shs Outstand28.37M Perf Week3.87%
Market Cap411.32M Forward P/E32.22 EPS next Y0.45 Insider Trans1.30% Shs Float26.67M Perf Month-3.65%
Enterprise Value912.41M PEG- EPS next Q0.08 Inst Own81.95% Short Float3.84% Perf Quarter-10.77%
Income-10.39M P/S3.48 EPS this Y-4.35% Inst Trans1.84% Short Ratio4.13 Perf Half Y-9.43%
Sales118.10M P/B0.94 EPS next Y287.50% ROA-1.07% Short Interest1.02M Perf YTD-24.52%
Book/sh15.43 P/C84.63 EPS next 5Y- ROE-2.22% 52W High20.87 -30.52% Perf Year-14.35%
Cash/sh0.17 P/FCF11.28 EPS past 3/5Y- - ROIC-1.10% 52W Low13.23 9.60% Perf 3Y-53.57%
Dividend Est.- EV/EBITDA14.99 Sales past 3/5Y8.53% 13.73% Gross Margin43.52% Volatility2.35% 2.47% Perf 5Y-69.99%
Dividend TTM1.88 (12.93%) EV/Sales7.73 EPS Y/Y TTM-877.53% Oper. Margin14.67% ATR (14)0.35 Perf 10Y-23.44%
Dividend Ex-DateNov 07, 2025 Quick Ratio3.31 Sales Y/Y TTM2.96% Profit Margin-8.80% RSI (14)51.46 Recom1.80
Dividend Gr. 3/5Y2.08% 2.20% Current Ratio3.31 EPS Q/Q-18.78% SMA201.78% Beta0.69 Target Price18.90
Payout- Debt/Eq1.16 Sales Q/Q5.70% SMA50-2.27% Rel Volume1.07 Prev Close14.59
Employees36 LT Debt/Eq1.16 EarningsOct 28 AMC SMA200-13.27% Avg Volume247.81K Price14.50
IPOMay 21, 2015 Option/ShortYes / Yes EPS/Sales Surpr.-284.62% -0.04% Trades Volume264,128 Change-0.62%
Date Action Analyst Rating Change Price Target Change
Sep-16-24Upgrade Evercore ISI Underperform → In-line $21 → $18
May-01-24Downgrade Piper Sandler Overweight → Neutral $36 → $26
Nov-02-23Downgrade Evercore ISI Outperform → In-line $36 → $32
Sep-22-23Downgrade Robert W. Baird Outperform → Neutral $43 → $33
Jan-13-23Upgrade Janney Neutral → Buy $44
Nov-25-20Upgrade Evercore ISI In-line → Outperform
Nov-05-20Reiterated B. Riley Securities Neutral $47 → $49
Sep-30-20Resumed Robert W. Baird Outperform $51
Sep-09-20Initiated Colliers Securities Buy $52
Jun-08-20Downgrade Evercore ISI Outperform → In-line $43
Oct-27-25 09:41AM
Oct-23-25 06:05PM
Oct-03-25 04:30PM
09:50AM
Jul-31-25 03:24AM
06:30PM Loading…
Jul-29-25 06:30PM
05:40PM
04:30PM
09:57AM
Jul-28-25 09:36AM
Jul-24-25 04:30PM
Jul-01-25 05:40PM
Jun-11-25 06:09PM
Jun-04-25 10:31AM
May-06-25 04:30PM
07:21AM Loading…
07:21AM
May-03-25 09:54AM
01:26AM
May-01-25 03:14AM
Apr-30-25 01:56PM
Apr-29-25 07:00PM
05:45PM
04:43PM
04:30PM
Apr-24-25 05:44PM
Apr-11-25 10:01PM
Apr-10-25 10:27AM
Apr-07-25 07:30AM
Apr-02-25 06:00PM
Feb-20-25 02:09AM
12:33AM Loading…
12:33AM
Feb-19-25 04:54AM
Feb-18-25 06:30PM
05:50PM
05:00PM
04:30PM
02:50AM
Feb-13-25 05:42PM
Jan-16-25 05:15PM
Dec-18-24 09:40AM
Dec-13-24 08:30PM
Dec-02-24 02:21PM
Nov-15-24 09:40AM
Oct-31-24 04:08AM
04:06AM
03:13AM
Oct-29-24 06:30PM
05:45PM
04:43PM
04:30PM
09:15AM
09:00AM
Oct-28-24 09:07AM
Oct-24-24 06:00PM
Oct-20-24 02:39PM
Oct-17-24 03:08PM
Oct-16-24 04:30PM
Oct-09-24 03:34PM
05:29AM
Oct-04-24 06:15AM
Oct-01-24 06:19PM
Sep-11-24 01:17PM
Sep-06-24 06:43PM
Aug-06-24 11:30PM
Aug-05-24 03:00PM
Jul-30-24 07:00PM
06:05PM
05:03PM
04:30PM
Jul-25-24 07:51PM
Jul-03-24 09:00AM
May-21-24 05:21PM
May-02-24 08:46AM
07:08AM
03:22AM
12:59AM
Apr-30-24 09:53PM
07:00PM
05:57PM
05:45PM
04:43PM
04:30PM
Apr-28-24 09:57AM
Apr-25-24 05:43PM
Apr-05-24 04:45PM
Feb-15-24 08:45AM
Feb-13-24 07:00PM
06:00PM
05:34PM
05:06PM
04:45PM
Feb-12-24 12:39PM
Feb-08-24 07:13PM
Jan-23-24 04:45PM
Nov-02-23 09:29AM
Nov-01-23 11:48PM
Oct-31-23 07:30PM
06:16PM
06:15PM
05:09PM
Community Healthcare Trust, Inc. is a healthcare real estate company, which engages in acquiring real estate properties that are leased to hospitals, doctors, healthcare systems or other healthcare service providers. The company was founded by Timothy G. Wallace, William Page Barnes, Leigh Ann Stach, Ron Hart, Bill Davis, Stephen M. Harrison, Mike Willman, and Jim Short on March 28, 2014 and is headquartered in Franklin, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Van Horn R. LawrenceDirectorMay 28 '25Buy16.3711,815193,41288,502May 30 05:33 PM
Dupuy David H.CEO and PresidentMay 13 '25Buy16.2310,000162,300458,500May 14 04:15 PM
Cotman CathrineDirectorApr 30 '25Buy17.103,00051,30023,861May 02 04:19 PM
Cotman CathrineDirectorApr 30 '25Sale17.093,00051,27020,861May 02 04:19 PM
Last Close
Oct 27  •  04:00PM ET
38.24
Dollar change
-0.28
Percentage change
-0.73
%
HROW Harrow Inc daily Stock Chart
IndexRUT P/E- EPS (ttm)-0.30 Insider Own16.60% Shs Outstand36.71M Perf Week-9.23%
Market Cap1.41B Forward P/E21.32 EPS next Y1.79 Insider Trans-0.81% Shs Float30.86M Perf Month-18.81%
Enterprise Value1.59B PEG- EPS next Q0.21 Inst Own57.46% Short Float18.47% Perf Quarter10.74%
Income-10.23M P/S6.22 EPS this Y174.49% Inst Trans3.02% Short Ratio8.12 Perf Half Y55.13%
Sales227.66M P/B28.28 EPS next Y391.44% ROA-3.14% Short Interest5.70M Perf YTD13.98%
Book/sh1.35 P/C26.72 EPS next 5Y- ROE-18.99% 52W High54.19 -29.43% Perf Year-29.47%
Cash/sh1.43 P/FCF557.07 EPS past 3/5Y10.79% - ROIC-10.60% 52W Low20.85 83.41% Perf 3Y223.52%
Dividend Est.- EV/EBITDA48.83 Sales past 3/5Y40.17% 31.29% Gross Margin74.56% Volatility4.71% 6.15% Perf 5Y594.01%
Dividend TTM- EV/Sales7.00 EPS Y/Y TTM69.57% Oper. Margin6.44% ATR (14)2.36 Perf 10Y466.52%
Dividend Ex-Date- Quick Ratio0.58 Sales Y/Y TTM47.69% Profit Margin-4.49% RSI (14)41.78 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.62 EPS Q/Q170.78% SMA20-7.26% Beta0.20 Target Price68.17
Payout- Debt/Eq4.66 Sales Q/Q30.25% SMA50-7.07% Rel Volume0.62 Prev Close38.52
Employees382 LT Debt/Eq0.94 EarningsNov 10 AMC SMA20018.23% Avg Volume702.08K Price38.24
IPOApr 24, 2007 Option/ShortYes / Yes EPS/Sales Surpr.1633.33% -3.42% Trades Volume436,357 Change-0.73%
Date Action Analyst Rating Change Price Target Change
Jul-11-25Initiated Cantor Fitzgerald Overweight $76
Jun-12-25Initiated BTIG Research Buy $62
Jun-10-25Initiated William Blair Outperform
Feb-06-25Initiated H.C. Wainwright Buy $57
Dec-04-24Reiterated B. Riley Securities Buy $73 → $69
Apr-11-24Initiated Craig Hallum Buy $24
Sep-08-22Resumed B. Riley Securities Buy $17
Oct-14-21Resumed B. Riley Securities Buy $16
Sep-24-21Initiated Aegis Capital Buy $15
Jul-02-21Initiated Ladenburg Thalmann Buy $14.25
Oct-27-25 07:00AM
Oct-08-25 11:23AM
Oct-06-25 07:00AM
Sep-26-25 08:57AM
07:00AM
04:05PM Loading…
Sep-25-25 04:05PM
Sep-15-25 07:00AM
Sep-08-25 05:57PM
08:00AM
Sep-02-25 04:07AM
Aug-26-25 04:15AM
Aug-15-25 12:20PM
10:00AM
09:55AM
Aug-14-25 02:36PM
05:55PM Loading…
Aug-11-25 05:55PM
04:01PM
09:23AM
Aug-08-25 09:22AM
Aug-06-25 07:00AM
Aug-04-25 10:00AM
Jul-29-25 07:00AM
Jul-21-25 03:34PM
Jul-17-25 07:00AM
07:00AM
Jul-14-25 10:01AM
Jul-12-25 09:40AM
Jul-11-25 09:38AM
Jul-06-25 04:15AM
Jul-02-25 09:00AM
07:00AM Loading…
Jun-18-25 07:00AM
Jun-09-25 07:00AM
May-14-25 10:07AM
07:00AM
May-10-25 03:03AM
May-08-25 05:10PM
04:01PM
09:32AM
May-07-25 10:28AM
May-05-25 07:00AM
Apr-30-25 07:35AM
Apr-29-25 07:35AM
Apr-24-25 10:00AM
Apr-21-25 04:26PM
Apr-10-25 07:00AM
Mar-29-25 04:30PM
03:01PM
Mar-28-25 02:00PM
01:39PM
Mar-27-25 06:45PM
04:01PM
10:45AM
Mar-24-25 07:00AM
Mar-21-25 10:56PM
Mar-19-25 05:18PM
Mar-17-25 04:01PM
07:00AM
Mar-11-25 07:00AM
Mar-03-25 07:15AM
Feb-07-25 09:40AM
Jan-27-25 07:30AM
Jan-07-25 07:00AM
Nov-21-24 07:00AM
Nov-20-24 07:00AM
Nov-15-24 07:00AM
02:06AM
Nov-13-24 04:34PM
07:16AM
07:00AM
Nov-12-24 07:00AM
Nov-07-24 07:00AM
Oct-31-24 07:00AM
Oct-10-24 07:00AM
Oct-03-24 07:00AM
Oct-02-24 11:10AM
Sep-25-24 12:02PM
Sep-03-24 07:00AM
Aug-07-24 04:01PM
Jul-25-24 07:00AM
Jul-12-24 07:00AM
Jul-09-24 07:00AM
Jul-02-24 11:52AM
Jun-20-24 07:00AM
Jun-07-24 06:30AM
Jun-06-24 08:00AM
Jun-05-24 07:00AM
May-15-24 07:00AM
May-13-24 08:55PM
04:25PM
04:01PM
07:00AM
Apr-25-24 07:00AM
Apr-02-24 08:16AM
Mar-21-24 09:55AM
Mar-19-24 09:52PM
06:51PM
05:45PM
Mar-13-24 06:35AM
Mar-05-24 07:00AM
Mar-04-24 08:28PM
Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAUM MARK LCHIEF EXECUTIVE OFFICERJul 21 '25Option Exercise7.87600,0004,722,0003,199,462Jul 23 09:10 PM
Opaleye Management Inc.10% OwnerJun 10 '25Sale30.8015,000462,03390,000Jun 11 04:15 PM
Opaleye Management Inc.10% OwnerJun 09 '25Sale30.3715,204461,794105,000Jun 11 04:15 PM
Opaleye Management Inc.10% OwnerJun 03 '25Sale30.043,00090,116122,000Jun 05 04:05 PM
Opaleye Management Inc.10% OwnerJun 04 '25Sale30.021,79653,907120,204Jun 05 04:05 PM
Opaleye Management Inc.10% OwnerMay 12 '25Sale25.9010,000258,959130,000May 14 04:56 PM
Opaleye Management Inc.10% OwnerMay 13 '25Sale26.595,000132,945125,000May 14 04:56 PM
BOLL ANDREW R.Chief Financial OfficerApr 03 '25Option Exercise0.00346,5000914,589Apr 07 09:55 PM
SAHAREK JOHN P.CEO & President, ImprimisRxApr 03 '25Option Exercise0.00277,2000576,863Apr 07 09:54 PM
BAUM MARK LChief Executive OfficerApr 03 '25Option Exercise0.00762,30002,899,825Apr 07 09:54 PM
Opaleye Management Inc.10% OwnerMar 18 '25Sale30.015,000150,055140,000Mar 26 04:05 PM
Opaleye Management Inc.10% OwnerMar 18 '25Sale29.645,000148,200145,000Mar 20 04:05 PM
Opaleye Management Inc.10% OwnerFeb 28 '25Sale28.055,000140,250150,000Mar 04 04:44 PM
Opaleye Management Inc.10% OwnerJan 22 '25Sale35.5920,000711,814155,000Jan 24 09:29 PM